Kryptomed Formulations Private Limited
Kryptomed Formulations Private Limited is a Private Non-govt company company incorporated in 2016 and based in Chandigarh, India. It was founded by Kirti, Anshul, and Vipin. Kryptomed Formulations Private Limited operates in Manufacture of pharmaceuticals, medicinal chemicals and botanical products (NIC 24230) with authorized capital of ₹10.00 L and paid-up capital of ₹1.00 L. For 2023-24, the company reported revenue of ₹6.30 Cr and profit after tax of ₹11.45 L. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Explore the financials, board members, legal insights, and much more in the complete profile of KRYPTOMED FORMULATIONS PRIVATE LIMITED.
Quick facts
Registered office location
Map position is derived from the address on the MCA register and may point to the locality rather than the exact door number. Verify against the company's own filings before relying on it for service of notice.
Directors
3 activeMCA Filings
LockedThe filing report for Kryptomed Formulations Private Limited covers its AOC-4 and MGT-7 record with the Registrar of Companies — form types, filing dates, due dates and delay in days.
Full MCA filing history for Kryptomed Formulations Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
LockedThe filing report for Kryptomed Formulations Private Limited covers its CHG-1 / CHG-4 record with the Registrar of Companies — charge IDs, lenders, secured amounts and open or satisfied status.
Charge IDs, lenders & amounts for Kryptomed Formulations Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +40.0% | +70.0% | +75.0% | |
| Profit after Tax2023-24 | +43.0% | +83.0% | +26.0% | |
| Net Worth2023-24 | +35.0% | +21.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | -13.14% | — | -94.48% | -15.09% | 6.26 | |||
| 2017-18 | +0.93% | +537.63% | — | +2.35% | — | |||
| 2018-19 | +1.31% | +53.31% | +132.33% | +3.61% | 36.70 | |||
| 2020-21 | +1.25% | +42.02% | +39.41% | +2.83% | 13.93 | |||
| 2021-22 | +1.54% | +45.61% | +41.40% | +3.95% | 10.49 | |||
| 2022-23 | +1.68% | +7.58% | +33.63% | +3.16% | 10.63 | |||
| 2023-24 | +1.82% | +23.26% | +31.28% | +4.09% | 7.65 |
Cap Table & Shareholding
LockedThe filing report for Kryptomed Formulations Private Limited covers its MGT-7 record with the Registrar of Companies — promoter, institutional and public holdings with share counts.
Promoter, institutional & public holding for Kryptomed Formulations Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
4 peersTop 10 in Manufacture of pharmaceuticals, medicinal chemicals and botanical products
by healthView all ›Events & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Kryptomed Formulations Private Limited
When was Kryptomed Formulations Private Limited incorporated?
Where is Kryptomed Formulations Private Limited located?
What sector does Kryptomed Formulations Private Limited operate in?
Who are the directors of Kryptomed Formulations Private Limited?
What is the paid-up capital of Kryptomed Formulations Private Limited?
Does Kryptomed Formulations Private Limited have any open charges?
What is Kryptomed Formulations Private Limited's Compliance Health Score?
Related Companies in Chandigarh
10Active companies with a registered address in Chandigarh — the entries closest to Kryptomed Formulations Private Limited in the MCA register. Tap any card for its full profile.